January 3, 2019
ATAI Life Sciences buys majority stake in NY-based Perception Neuroscience
ATAI Life Sciences AG has acquired a majority stake in New York based Perception Neuroscience, a biopharmaceutical company focused on developing innovative therapies in neuropsychiatry.